2022-2 – Contents
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies
█ Current opinion
Authors:
|
click here to read the summary |
click here to read the pdf |
Pulmonary vascular remodeling and right ventricular adaptation in precapillary pulmonary hypertension
█ Original article
DOI: 10.26430/CHUNGARICA.2022.52.2.105
Authors:
|
click here to read the summary |
click here to read the pdf |
Recommendations for the diagnosis and treatment of chronic heart failure according to the new ESC guideline published in 2021.
█ Review
DOI: 10.26430/CHUNGARICA.2022.52.2.112
Authors:
|
click here to read the summary |
click here to read the pdf |
The new European Heart Failure Guideline – ESC 2021. The role of SGLT2 inhibition based on evidences
█ Review
DOI: 10.26430/CHUNGARICA.2022.52.2.122
Authors:
|
click here to read the summary |
click here to read the pdf |
Current diagnostic and therapeutic strategies in cardiac amyloidosis – According to the position statement of the ESC Working Group of Myocardial and Pericardail Diseases in 2021
█ Review
DOI: 10.26430/CHUNGARICA.2022.52.2.130
Authors:
|
click here to read the summary |
click here to read the pdf |
Efficacy of SLGT-2 inhibitors in patients with heart failure or at high risk for cardiovascular events – a systematic review
█ Review
DOI: 10.26430/CHUNGARICA.2022.52.2.142
Authors:
|
click here to read the summary |
click here to read the pdf |
Adherence and psychosocial factors: possibilities of intervention from heart failure to cardiac transplantation
█ Review
DOI: 10.26430/CHUNGARICA.2022.52.2.151
Authors:
|
click here to read the summary |
click here to read the pdf |
A new chapter in blood pressure reduction: a distinction between thiazide-type and thiazide-like diuretics
█ Review
DOI: 10.26430/CHUNGARICA.2022.52.2.158
Authors:
|
click here to read the summary |
click here to read the pdf |